Alnylam Pharmaceuticals Aktie
382,20
EUR
-1,60
EUR
-0,42
%
445,10
USD
-1,12
USD
-0,25
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung